首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma
【2h】

The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma

机译:骨髓瘤患者结果量表是为临床开发的首个生活质量工具已在滤泡性淋巴瘤患者中得到验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ObjectivesThe development of novel agents and an ageing population has led to an increasing number of patients with follicular lymphoma (FL) living longer with their disease. Health‐related quality of life (HRQOL) is a priority for patients and should guide clinical decisions. The Myeloma Patient Outcome Scale (MyPOS), originally developed for myeloma, was validated in a cross‐sectional survey recruiting 124 FL patients.
机译:目的新型药物的开发和人口的老龄化导致越来越多的滤泡性淋巴瘤(FL)患者寿命更长。与健康相关的生活质量(HRQOL)是患者的首要任务,应指导临床决策。最初为骨髓瘤开发的骨髓瘤患者结果量表(MyPOS)在一项横断面调查中得到了验证,该研究招募了124名FL患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号